2Morrow Awarded DiMe Seal, Recognized for Excellence in Digital Behavior Change
'At 2Morrow, we believe that behavior change tools should be grounded in science, accessible to all, and built to scale. This recognition challenges all of us to keep raising the bar.'— Jo Masterson, CEO of 2Morrow
KIRKLAND, WA, UNITED STATES, June 3, 2025 / EINPresswire.com / -- 2Morrow has been named a recipient of the DiMe Seal, a new standard of excellence developed by the Digital Medicine Society (DiMe) in collaboration with Elevance Health. The Seal recognizes digital health software products that meet rigorous standards for clinical strength, usability, privacy, and equity.
With over 337,000 digital health apps available globally, the need for clarity and quality assurance has never been greater. The DiMe Seal was created to provide healthcare leaders with a trusted signal, identifying solutions that are not only innovative, but also backed by meaningful evidence and ready for real-world impact.
'The DiMe Seal is helping redefine how digital health earns trust,' said Jo Masterson, CEO of 2Morrow. 'We're proud to be part of this movement toward greater transparency and rigor. At 2Morrow, we believe that behavior change tools should be grounded in science, accessible to all, and built to scale. This recognition affirms that approach and challenges all of us to keep raising the bar.'
Elevating Evidence-Based Digital Care
2Morrow's Breathe Bundle - which includes programs for tobacco cessation, stress, weight, and personal goal setting - is the only multi-program solution of its kind recognized in the inaugural DiMe Seal cohort. Designed to support behavior change at scale, the programs are grounded in evidence-based approaches and principles drawn from Acceptance and Commitment Therapy (ACT).
As part of the evaluation process, which included independent review and clinical input from Elevance Health, one of the nation's largest payers, 2Morrow received a 'Strong' recommendation for its clinical evidence. The assessment highlighted randomized trial results, a transparent evidence base, and strong usability across a broad range of populations.
Building a More Trusted Future in Digital Health
2Morrow is proud to be among the first companies to earn this designation and to stand alongside a diverse group of innovators working to define quality in digital health. According to the IQVIA Digital Health Trends 2024 report, only a small fraction of digital health solutions offer published evidence of clinical impact, making initiatives like the DiMe Seal increasingly vital to helping healthcare leaders make confident, informed decisions.
'The influx of innovative digital health software products in our healthcare system can transform how we deliver care, but healthcare leaders need a clear, reliable way to identify which solutions are ready to deliver impact,' said Doug Mirsky, Vice President, DiMe Seal. 'The DiMe Seal offers that clarity, and we're proud to help elevate organizations like 2Morrow that are building products that exemplify the evidence-backed, scalable innovation the healthcare system needs.'
The DiMe Seal reflects a broader shift across the healthcare ecosystem: a demand for solutions that don't just promise change, but can prove it. For organizations seeking digital programs that are practical, proven, and ready to implement, the Seal provides a new level of confidence.
Learn more about the DiMe Seal here.
About 2Morrow: 2Morrow is a leading provider of evidence-based digital behavioral health and wellness solutions, including tobacco cessation. Our efforts in assisting people to quit smoking have consistently yielded positive outcomes, supported by a Phase III randomized controlled trial involving 2,400 participants and more than 12 peer-reviewed publications. Trusted by some of the nation's largest employers, states, and health plans, we've empowered over a million individuals on their journey to improved health, showcasing our dedication to expanding access to care. At 2Morrow, we're committed to using innovative technology and research to drive impactful change and expand access to care. For more information, please visit www.2morrowinc.com.
Deanna Waters
2Morrow
[email protected]
Visit us on social media:
LinkedIn
Facebook
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Shoppers 'genuinely shocked' by side effect of Coles, Bunnings, Woolworths, Mitre 10 product
For years, Coles, Woolworths, Bunnings, Mitre 10, and other major retailers have been knowingly and legally selling a poison to consumers with a deadly side effect. It's quietly killing off Australia's native animals. Now Yahoo News can reveal more than 280 vets, doctors, farmers, scientists, and conservationists have signed an open letter calling on the nation's chemical regulator to ban merchants from selling this 'highly-toxic' form of rat bait to consumers. Second-generation anticoagulant rodenticides (SGARs) are openly sold on the same shelves as less harmful first-generation poisons, traps and natural baits. Although there are warnings on packets, unless shoppers delve into the fine print, they're unlikely to be able to tell the difference, and experts believe only professionals should be able to use these products because they're so dangerous. The letter has been sent from BirdLife Australia to the Australian Pesticides and Veterinary Medicines Authority (APVMA) as it is conducting a review of SGARs. It notes the United States, Canada, and the European Union have all introduced 'significant restrictions' to reduce the risk of 'unintended harm' caused by these products. 'Australia is lagging behind, allowing the continued use of SGARs in a way that is putting our wildlife and pets at risk,' it warns, dubbing it a 'crisis' that needs 'immediate intervention'. BirdLife Australia's Dr Holly Parsons told Yahoo News SGARs have a commercial purpose, however most consumers are 'genuinely shocked' that these baits are sold in supermarkets and hardware stores for home use when they can harm owls, native mammals, and even pets. 'There's a perception that because you can buy it on the shelf it's safe to use, and if you use it in accordance with the directions there's not going to be a problem. But that's not the case,' she said. Related: 😳 Bunnings workers struggle to spot deadly product on shelf SGARs were developed in the 1980s to combat growing resistance by rats to first-generation rodenticides. But these new poisons don't break down quickly in the environment, meaning each time a non-target animal eats a rat or mouse, they will accumulate more poison in their body. Sometimes the poisons will directly kill animals by making them slowly bleed out. But often they make non-target species so sick they get hit by cars or become unable to hunt. It's long been known that predatory birds like owls and tawny frogmouths frequently succumb to SGARs. Sadly, it's unpaid wildlife carers and volunteer vets who are left to mop up the problem when Aussies find sick and dying birds in their yards. In February, new research revealed native mammals like Tasmanian devils and quolls that are already threatened with extinction could be tipped over the edge by these chemicals. The signatories to the letter warn the problem is so serious that SGARs will soon be nominated as a Key Threatening Process under the Environment Protection and Biodiversity Conservation (EPBC) Act – Commonwealth legislation designed to safeguard endangered species. This would place SGARs alongside other major threats to the survival, abundance, or evolutionary development of native species, with other examples including feral animals, land clearing and chytrid fungus, which has directly caused the extinction of seven frog species in Australia. 'This issue is critical, and the urgency cannot be overstated. The ongoing use of SGARs presents a severe and immediate threat to Australia's wildlife and pets,' the letter says. Parsons told Yahoo the problem is continuing to 'grow deeper' the more we research it and that APVMA needed to act. 'More and more, we're understanding these products are getting out further than we ever expected them to. Many people probably don't realise that their backyard is part of the local environment, and so the impact of what they do inside their home is going to have ramifications for the wildlife around them,' she said. 📸 Beach find highlights dark side of Queensland's $88 million tourism pledge Dangerous discovery made 30cm under Western Australian garden 🌏 Alarming map highlights growing threats to $3.8 billion industry In 2023, pressure on Bunnings to stop selling animal glue traps proved effective, with the retailer confirming they would phase them out. These products had been linked to wildlife harm, and in this case Bunnings acted without being forced to by new regulations. Some campaigners had also hoped the retailer would withdraw SGARs from consumer sale without the need for the government to intervene. Yahoo visited Bunnings and Coles stores and saw SGARs on shelves beside less harmful products. And while this may be confusing for some consumers, the retailers are complying with all current legal guidelines with their displays. Active ingredients in SGARs-based products include brodifacoum, bromadiolone, difethialone, difenacoum, and flocoumafen. An update on their use by the APVMA is expected this year. Birdlife Australia's 281 signatories include biodiversity expert Professor Martine Maron, environmental scientist Professor Raylene Cooke, former Queensland chief scientist Professor Hugh Possingham, and molecular scientist Associate Professor Bill Bateman. They are calling for the following seven changes: SGARs to be withdrawn from public sale and their use restricted to licensed professionals. A ban on their use outside of buildings. Promotion of alternatives like electronic traps and non-anticoagulant options. Develop new management strategies that prioritise non-chemical alternatives. Mandate the monitoring of SGAR impacts on wildlife. Establish buffer zones around ecologically sensitive areas. Develop a threat abatement plan to address rodenticide contamination in the environment. Coles was contacted for comment, but it did not immediately respond. Metcash's Independent Hardware Group (IHG), which supplies Mitre 10 stores with products including SGARs, told Yahoo News it "will comply" with any directives legislated by the APVMA. "In the interim, we are working with suppliers to produce educational materials for members and consumers around the use of alternative products," it said in a statement. "While we cannot compel independent Mitre 10 stores to display signage, it will be strongly encouraged. We are also in the process of extending our range of natural, pallet-based throw packs that are non-toxic to birds and other wildlife." Bunnings said it had worked with the APVMA and suppliers to update packaging to "clearly display" on the front when SGARs are present, and introduced QR codes in rodent control aisles so customers can learn more about products. "The rodenticide products we sell are in line with guidance from the Federal regulator, the APVMA, and we will continue to follow its advice in this area. This includes any requirements confirmed by the APVMA when the Anticoagulant Rodenticides Chemical Review is finalised," a spokesperson said. Bunnings added that it was providing "choice" for consumers, and that included both rodenticides and non-poisonous alternatives to help customers achieve the "best solution to their specific rodent problem". Woolworths said the products are "important" for people who have issues with rats or mice, particularly in rural areas. It also sells them in metropolitan and suburban stores. "We also sell a number of alternative options including ultrasonic repellents, traps and rodenticides without second-generation anticoagulants," it said. "As always, we encourage our customers to follow the instructions outlined on these products, which include clear labels and warnings about safe use, storage and disposal." You can read the full BirdLife Australia letter here. Love Australia's weird and wonderful environment? 🐊🦘😳 Get our new newsletter showcasing the week's best stories.
Yahoo
16 hours ago
- Yahoo
FARE Act expected to lower upfront costs for rentals: StreetEasy
NEW YORK CITY (PIX11) — The time is nearing for when New Yorkers will no longer have to pay a broker fee for renting apartments if they're not the hiring party. The Fairness in Apartment Rental Expenses (FARE) Act takes effect in a week and will make it so that brokers in NYC will have to be paid by the hiring party. Additionally, property managers or their brokers must disclose any fees a tenant must pay in their rental listings and rental agreements. More Lottery News Ahead of its enactment, real estate experts from StreetEasy are sharing their predictions for how the new law will impact renters. StreetEasy experts say residents will likely see upfront costs for rentals drop by as much as 41.8%. In the first half of 2025, the cost to sign a rental lease, including a broker fee, was averaged at $12,942. A cost that StreetEasy experts say has made it increasingly difficult for New Yorkers to find their next home. More: Latest News from Around the Tri-State After the FARE Act takes effect the average upfront cost to rent is expected to drop to about $7,537. While some have expressed concern that the broker fees may now be baked into the cost of rent, StreetEasy's real estate experts say the expected rent increases won't be much higher than broader market trends. Among properties that dropped broker fees ahead of the FARE Act, researchers found that rents were raised by 5.3%, which was only slightly higher than the average growth of 4.6% for apartments that maintained broker fees. The difference appears to indicate that property managers will likely absorb much of the additional cost incurred by bringing leasing activity in-house or covering rental brokers' fees directly, real estate experts say. Dominique Jack is a digital content producer from Brooklyn with more than five years of experience covering news. She joined PIX11 in 2024. More of her work can be found here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Miami Herald
16 hours ago
- Miami Herald
Trump budget bill would ban AI regulation. What Americans think of that in poll
A majority of Americans are against banning states from regulating artificial intelligence — a provision included in the latest congressional spending bill, according to new polling. A May 29 Common Sense Media/Echelon Insights survey found widespread concern about forcing states to sit on the sidelines as AI advances at a rapid clip, becoming increasingly embedded in everyday life. The poll comes after the GOP-controlled House passed the 'One Big Beautiful Bill,' as dubbed by President Donald Trump, which would bar states and localities from restricting AI development for a decade. 'No State or political subdivision thereof may enforce, during the 10-year period beginning on the date of the enactment of this Act, any law or regulation limiting, restricting, or otherwise regulating artificial intelligence models, artificial intelligence systems, or automated decision systems entered into interstate commerce,' the bill states. The legislation is now being considered in the Republican-controlled Senate, which is aiming to deliver it to Trump's desk by early July, as reported by CBS News. Here is a breakdown of the results from the poll: Opposition to AI regulation ban The poll — which sampled 1,022 voters May 20-22 — found that 59% of respondents somewhat or strongly oppose the provision banning AI regulation. Meanwhile, just 25% somewhat or strongly support it. Among Republicans, 50% said they are against the measure, while 31% said they support it. Further, a majority of overall respondents, 52%, said the moratorium makes them less likely to support the GOP-backed spending bill. And just 15% said it makes them more inclined to support the legislation. Voters also signaled that they have more faith in state governments to manage the development of AI. Fifty-three percent said they have more trust in state and local leaders to 'regulate AI appropriately' than lawmakers in Washington, D.C. Meanwhile, 15% said they place more trust in federal lawmakers. The survey — which has a margin of error of 3.4 percentage points — also asked respondents to react to a series of statements, with the results further indicating there is far-reaching concern about AI regulation. For example, 77% of respondents agreed with the statement 'States should have the right to make laws about technology, and Congress should not take that right away from them.' Just 13% disagreed. An even larger share, 81%, agreed with the statement 'Advances in AI are exciting but also bring risks, and in such fast-moving times, we shouldn't force states to sit on the sidelines for a full decade.' Meanwhile, 11% disagreed with this. The same 81% share also agreed with the statement 'Congress should not ban states from enacting or enforcing their own laws when it comes to protecting kids' safety and privacy online.' Twelve percent disagreed. This comes as several states have put forward laws protecting the privacy of minor's online that explicitly relate to AI. For example, California's Leading Ethical Development of AI (LEAD) Act, introduced in February, would require parents to consent before AI developers use a child's information to train AI models. 'The numbers are clear,' Kristen Soltis Anderson, the co-founder of Echelon Insights, said in a news release. 'Voters are concerned about the potential dangers AI-generated content can pose to kids and teens, and say they don't want the federal government to tell states what they can and can't do about the issue.' James Steyer, the CEO of Common Sense Media, added that the AI provisions in the budget leave Americans 'to fend for themselves against the most powerful technology of our time.' AI experts project that the technology will develop at an exceptionally fast pace, with significant advancements expected in the near term. For example, the 2025 Stanford AI Index Report highlights that AI capabilities — generative AI, in particular — have already accelerated dramatically, outstripping some previous forecasts.
